Search results

ANSTO’s Radioanalytical Chemistry (RAC) facility combines techniques in radiochemistry and radiological measurement by alpha spectrometry, gamma-ray spectrometry, and liquid scintillation analysis to deliver radiological assessments.

nandin is ANSTO’s Innovation Centre where science and technology entrepreneurs, startups and graduates meet industry expertise to experiment, co-create, innovate, and commercialise, creating new jobs in the high-growth industries of tomorrow.

Three new federal grants were announced to support manufacturing and nuclear technologies.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

Since 1962, the United Uranium Scholarship has helped promising young scientists in the field of nuclear energy extend their knowledge and expertise. In 2022, scholarships were awarded to several ANSTO researchers, including Phil Sutton.

It is critical across many industries to identify and locate sources of radiation accurately and quickly. By accurately imaging radiation across the full energy range, CORIS360™ improves operational decision making across many industry settings.

Accelerator Mass Spectrometry (AMS) is an ultra-sensitive analytical technique based on the use of an ion accelerator as a powerful mass spectrometer.

ANSTO will participate in a New Zealand Marsden project which will search for chemical clues linked to the origins of life on Titan, Saturn’s largest moon. 

PHD student Dr Leonie van ‘t Hag has been awarded the prestigious 2017 ANSTO, Australian Synchrotron Stephen Wilkins Medal for her PhD thesis.

Strategic partnership with the University of Sydney expanded to continue a long history of research collaboration.

Planetary science is an emerging research theme in Australia, and research at ANSTO is embedded in the heart of this.

The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.

The ANSTO Awards in Nuclear Science and Technology 2018 were presented on Friday 2 November at The Australian Museum, and showcased ANSTO’s unique nuclear science and technology capabilities, which enable progress in the key areas of health research and innovation for industry.

ANSTO and the National University of Singapore have signed an agreement to enable Singapore researchers to access ANSTO’s state-of-the-art beamline facilities at the Australian Synchrotron.